• Home
  •  / ProterixBio

ProterixBio

  • Total Funding$90.2 M

OverviewSuggest Edit

ProterixBio (formerly known as BioScale) is a company that develops proprietary blood-based biomarker tests to transform the management of chronic respiratory diseases. It provides chronic care platforms to improve patient outcomes, starting with pulmonary diseases.

TypePrivate
Founded2002
HQBillerica, MA, USMap
Websiteproterixbio.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jul 2022)19
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at ProterixBio

Grace Colón

Grace Colón

Executive Chairman
Brett P. Masters

Brett P. Masters

Chief Technology Officer
Charles L. Popkin

Charles L. Popkin

Chief Financial Officer
Edward F. Crawley

Edward F. Crawley

MIT and Co-Founder
Mark Lundstrom

Mark Lundstrom

Director
Show more

ProterixBio Office Locations

ProterixBio has an office in Billerica
Billerica, MA, US (HQ)
1 Fortune Dr
Show all (1)

ProterixBio Financials and Metrics

Summary Metrics

Founding Date

2002

ProterixBio total Funding

$90.2 m

ProterixBio latest funding size

$18.8 m

Time since last funding

9 years ago

ProterixBio investors

New York Angels, New Science Ventures, Morningside Group, MF Capital, Blackfin Technology, F2 Ventures, WFD Ventures
ProterixBio's latest funding round in July 2013 was reported to be $18.8 m. In total, ProterixBio has raised $90.2 m
Show all financial metrics

ProterixBio Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

Learn more about our premium products
SecurityScorecard logo

ProterixBio Online and Social Media Presence

ProterixBio's Trends

Embed Graph

ProterixBio Blogs

August 10, 2021

Help us by volunteering to evaluate an investigational at-home COVID-19 antibody test

Help us by volunteering to evaluate an investigational at-home COVID-19 antibody test. Currently enrolling non-vaccinated COVID-19 volunteers. We ship the kits to all 50 states. Please follow the link to sign up: https://c0hbs336.caspio.com/dp/b6549000111ef5514a8d4cdbb137      The post Help us by vo…
February 11, 2021

ProterixBio announces commercial availability of a quantitative COVID-19 serology test validated for dried blood spots from a finger stick

Billerica, MA, February 11, 2020: ProterixBio, Inc. announced today commercial availability of a quantitative COVID-19 serology assay that has been validated for dried blood spots (DBS) from a finger stick. This is an update to the previously released SARS-CoV-2 (RBD) IgG Antibody test and is being …

 ProterixBio Frequently Asked Questions

  • When was ProterixBio founded?

    ProterixBio was founded in 2002.

  • Who are ProterixBio key executives?

    ProterixBio's key executives are Grace Colón, Brett P. Masters and Charles L. Popkin.

  • How many employees does ProterixBio have?

    ProterixBio has 19 employees.

  • Who are ProterixBio competitors?

    Competitors of ProterixBio include MiCo BioMed, Humasis and DiaSys Diagnostic Systems.

  • Where is ProterixBio headquarters?

    ProterixBio headquarters is located at 1 Fortune Dr, Billerica.

  • Where are ProterixBio offices?

    ProterixBio has an office in Billerica.

  • How many offices does ProterixBio have?

    ProterixBio has 1 office.